1[1]Torres PF, Kijlstra A. The role of eytokines in corneal immunopathology. Ocul- Immunol- Inflamm, 2001; 9(1): 9-24.
2[2]Culton M, Chandler DB, Proia AD, et al. The effect of oxygen on corneal neovascularization. Invest - Ophthalmol - Vis - Sci, 1990; 31(7): 1277 - 1281.
3[3]Cursiefen C, Kuchle M, Naumann, GO. Angingenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovaseularization. Cornea, 1998; 17(6) :611 - 613.
4[4]David G, Cogan MD. Studies on the clinical physiology of the cornea.Am J Ophthalmology, 1949; 32:625 - 633.
6[6]Kruse FE, Volcker HE. Stem ceils, wound healing, growth factors, and angiogenesis in the cornea. Curr- Opin- Ophthalmol, 1997; 8(4): 46- 54.
7[7]Becker MD, Kruse FE, Azzam L. In vivo. significance of ICAM - 1dependent leukocyte adhesion in early corneal angiogenesis. InvestOphthalmol - Vis - Sci, 1999; 40(3) :612 - 618.
8[8]Ma DH, Tsai RJ, ChuWK, et al. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest - Ophthalmol- Vis - Sci, 1999; 40(8): 1822 - 1828.
9[9]Mieyal PA, Bonazzi A, Jiang H, et al. The effect of hypoxia on endogenous corneal epithelial eicosanoids. Invest - Ophthalmol - Vis - Sci,2000; 41(8): 2170- 2176.
10[10]Binetruy- Toumaire R, Demangel C, Malavaud B, et al. Identification of a peptide blocking vascular endothelial growth factor (VEGF)mediated angiogenesis. EMBO- J, 2000; 19(7): 1525- 1533.
